84
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Synthesis, characterization, and evaluation of poly (D,L-lactide-co-glycolide)-based nanoformulation of miRNA-150: potential implications for pancreatic cancer therapy

, , , , , , & show all
Pages 2933-2942 | Published online: 18 Jun 2014

References

  • LongJZhangYYuXOvercoming drug resistance in pancreatic cancerExpert Opin Ther Targets20111581782821391891
  • SiegelRNaishadhamDJemalACancer statistics, 2013CA Cancer J Clin201363113023335087
  • AroraSBhardwajASinghSAn undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor κB- and hypoxia-inducible factor 1α-mediated up-regulation of CXCR4J Biol Chem201319288211972120723740244
  • Alvarez-GarciaIMiskaEAMicroRNA functions in animal development and human diseaseDevelopment20051324653466216224045
  • BhardwajASinghSSinghAPMicroRNA-based Cancer Therapeutics: Big Hope from Small RNAsMol Cell Pharmacol2010221321921289871
  • BushatiNCohenSMmicroRNA functionsAnnu Rev Cell Dev Biol20072317520517506695
  • SrivastavaSKBhardwajALeavesleySJGrizzleWESinghSSinghAPMicroRNAs as potential clinical biomarkers: emerging approaches for their detectionBiotech Histochem20138837338723293934
  • SrivastavaSKBhardwajASinghSMicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cellsCarcinogenesis2011321832183921983127
  • KobayashiEHornicekFJDuanZMicroRNA Involvement in OsteosarcomaSarcoma2012201235973922550419
  • PecotCVCalinGAColemanRLLopez-BeresteinGSoodAKRNA interference in the clinic: challenges and future directionsNat Rev Cancer201111596721160526
  • IbraheemDElaissariAFessiHGene therapy and DNA delivery systemsInt J Pharm2014459708324286924
  • RaziSSBaradaranBLotfipourFKazemiTMohammadnejadLGene therapy, early promises, subsequent problems, and recent breakthroughsAdv Pharm Bull2013324925524312844
  • YoungLSSearlePFOnionDMautnerVViral gene therapy strategies: from basic science to clinical applicationJ Pathol200620829931816362990
  • ItakaKKataokaKRecent development of nonviral gene delivery systems with virus-like structures and mechanismsEur J Pharm Biopharm20097147548318955136
  • SchagenFHOssevoortMToesREHoebenRCImmune responses against adenoviral vectors and their transgene products: a review of strategies for evasionCrit Rev Oncol Hematol200450517015094159
  • AignerANonviral in vivo delivery of therapeutic small interfering RNAsCurr Opin Mol Ther2007934535217694447
  • MerdanTKopecekJKisselTProspects for cationic polymers in gene and oligonucleotide therapy against cancerAdv Drug Deliv Rev20025471575812204600
  • ZhouJShumKTBurnettJCRossiJJNanoparticle-Based Delivery of RNAi Therapeutics: Progress and ChallengesPharmaceuticals (Basel)201368510723667320
  • TyagiNRathoreSSGhoshPCEnhanced killing of human epidermoid carcinoma (KB) cells by treatment with ricin encapsulated into sterically stabilized liposomes in combination with monensinDrug Deliv20111839440421438723
  • DanhierFAnsorenaESilvaJMCocoRLe BretonAPréatVPLGA-based nanoparticles: an overview of biomedical applicationsJ Control Release201216150552222353619
  • LangerRTirrellDADesigning materials for biology and medicineNature200442848749215057821
  • PatilYPanyamJPolymeric nanoparticles for siRNA delivery and gene silencingInt J Pharm200936719520318940242
  • SinghSSrivastavaSKBhardwajAOwenLBSinghAPCXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapyBr J Cancer20101031671167921045835
  • ChaturvediPSinghAPChakrabortySMUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cellsCancer Res2008682065207018381409
  • JainAKDasMSwarnakarNKJainSEngineered PLGA nanoparticles: an emerging delivery tool in cancer therapeuticsCrit Rev Ther Drug Carrier Syst20112814521395514
  • KesharwaniPGajbhiyeVJainNKA review of nanocarriers for the delivery of small interfering RNABiomaterials2012337138715022796160
  • PanyamJLabhasetwarVBiodegradable nanoparticles for drug and gene delivery to cells and tissueAdv Drug Deliv Rev20035532934712628320
  • WangJLuZWientjesMGAuJLDelivery of siRNA therapeutics: barriers and carriersAAPS J20101249250320544328
  • BarichelloJMMorishitaMTakayamaKNagaiTEncapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation methodDrug Dev Ind Pharm19992547147610194602
  • CohenHLevyRJGaoJSustained delivery and expression of DNA encapsulated in polymeric nanoparticlesGene Ther200071896190511127577
  • KhanABenboubetraMSayyedPZSustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studiesJ Drug Target20041239340415545089
  • PanyamJZhouWZPrabhaSSahooSKLabhasetwarVRapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene deliveryFASEB J2002161217122612153989
  • ReadMLSinghSAhmedZA versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acidsNucleic Acids Res200533e8615914665
  • ZhuLMahatoRILipid and polymeric carrier-mediated nucleic acid deliveryExpert Opin Drug Deliv201071209122620836625
  • PatilYBSwaminathanSKSadhukhaTMaLPanyamJThe use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistanceBiomaterials20103135836519800114
  • TaharaKSakaiTYamamotoHTakeuchiHKawashimaYEstablishing chitosan coated PLGA nanosphere platform loaded with wide variety of nucleic acid by complexation with cationic compound for gene deliveryInt J Pharm200835421021618178349
  • DinarvandRSepehriNManoochehriSRouhaniHAtyabiFPolylactide-co-glycolide nanoparticles for controlled delivery of anticancer agentsInt J Nanomedicine2011687789521720501
  • GaumetMVargasAGurnyRDelieFNanoparticles for drug delivery: the need for precision in reporting particle size parametersEur J Pharm Biopharm2008691917826969
  • TyagiNGhoshPCFolate receptor mediated targeted delivery of ricin entrapped into sterically stabilized liposomes to human epidermoid carcinoma (KB) cells: effect of monensin intercalated into folate-tagged liposomesEur J Pharm Sci20114334335321621613
  • KimJHParkJSYangHNThe use of biodegradable PLGA nanoparticles to mediate SOX9 gene delivery in human mesenchymal stem cells (hMSCs) and induce chondrogenesisBiomaterials20113226827820875683
  • PrabhaSZhouWZPanyamJLabhasetwarVSize-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticlesInt J Pharm200224410511512204570
  • IshidaOMaruyamaKSasakiKIwatsuruMSize-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing miceInt J Pharm1999190495610528096
  • HallJBDobrovolskaiaMAPatriAKMcNeilSECharacterization of nanoparticles for therapeuticsNanomedicine (Lond)2007278980318095846
  • UtrejaPJainSTiwaryAKNovel drug delivery systems for sustained and targeted delivery of anti-cancer drugs: current status and future prospectsCurr Drug Deliv2010715216120158482
  • IorioMVCroceCMMicroRNAs in cancer: small molecules with a huge impactJ Clin Oncol2009275848585619884536